Loading...
Publication
Abordagem terapĂȘutica da DPOC: nova estratĂ©gia
| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| PPG_17279 | 1.13 MB | Adobe PDF |
Authors
Advisor(s)
Abstract(s)
A Doença Pulmonar Obstrutiva CrĂłnica (DPOC) Ă© uma patologia que tem sido considerada como sendo um problema de saĂșde a nĂvel mundial devido a sua elevada prevalĂȘncia, morbilidade e mortalidade. A contĂnua exposição aos vĂĄrios fatores de risco bem como Ă s comorbilidades associadas estĂŁo na base do desenvolvimento da doença.
A DPOC apresenta um grande impacto a nĂvel social, fĂsico e psicolĂłgico desencadeando deste modo, mudanças na qualidade de vida dos doentes. Esta revisĂŁo bibliogrĂĄfica visa ilustrar os vĂĄrios fĂĄrmacos disponĂveis no mercado para o tratamento da DPOC, bem como apresentar novas estratĂ©gias e alternativas que tĂȘm vindo a surgir ao longo dos tempos.
A cessação tabĂĄgica Ă© a Ășnica medida que reduz efetivamente a progressĂŁo da doença e aumenta a sobrevida dos doentes. A terapia farmacolĂłgica Ă© capaz de reduzir os sintomas, exacerbaçÔes e complicaçÔes da doença. Ă capaz tambĂ©m de reduzir hospitalizaçÔes e custos associados aos internamentos, bem como melhorar a qualidade de vida dos doentes.
A deteção precoce da doença e tratamento imediato das exacerbaçÔes são essenciais para garantir os melhores resultados e para reduzir o impacto da DPOC na vida dos doentes.
The Chronic Obstructive Pulmonary Disease (COPD) is a pathology which has been regarded as a health issue worldwide due to its high prevalence, morbidity and mortality. Continuous exposure to several risk factors as well as associated comorbidities are both cause and reason for the development of the disease. COPD has a major social, physical and psychological impact, triggering in this order, changes in the quality of life of patients. This literature review aims to illustrate the various pharmaceutical drugs available in the market for the treatment of COPD, as well as to present new strategies and alternatives that have emerged over time. Smoking cessation is the only step that effectively reduces disease progression and improves patientâs health quality. Pharmacological therapy is able to reduce symptoms, complications and exacerbation of the disease. It is also able to reduce going to the hospital and associated costs with hospitalizations and improves the quality of life of the patients. Early detection of the disease and prompt treatment of exacerbations are essential to ensure the best results and to reduce the impact of COPD on patients' lives.
The Chronic Obstructive Pulmonary Disease (COPD) is a pathology which has been regarded as a health issue worldwide due to its high prevalence, morbidity and mortality. Continuous exposure to several risk factors as well as associated comorbidities are both cause and reason for the development of the disease. COPD has a major social, physical and psychological impact, triggering in this order, changes in the quality of life of patients. This literature review aims to illustrate the various pharmaceutical drugs available in the market for the treatment of COPD, as well as to present new strategies and alternatives that have emerged over time. Smoking cessation is the only step that effectively reduces disease progression and improves patientâs health quality. Pharmacological therapy is able to reduce symptoms, complications and exacerbation of the disease. It is also able to reduce going to the hospital and associated costs with hospitalizations and improves the quality of life of the patients. Early detection of the disease and prompt treatment of exacerbations are essential to ensure the best results and to reduce the impact of COPD on patients' lives.
Description
Keywords
Doença Pulmonar Obstrutiva Crónica Tratamento da DPOC Exacerbação na DPOC Tabagismo Fatores de risco Reabilitação pulmonar Chronic Obstructive Pulmonary Disease COPD treatment Exacerbations in COPD Smoking Risk factors Pulmonary rehabilitation